Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Guangdong Baodan Pharmaceutical is a Chinese pharmaceutical enterprise focused on the development, production, and sale of traditional Chinese medicines (TCM) and modern chemical drug products. Based in the Zhaoqing High-tech Zone, the company operates state-of-the-art GMP-certified manufacturing facilities and is recognized as a provincial-level high-tech enterprise. Its product portfolio features a wide range of formulations, including tablets, capsules, and granules targeting liver health, cardiovascular conditions, and respiratory ailments. Notable products include Hugan tablets and Compound Salvia Miltiorrhiza preparations, which integrate traditional pharmacology with modern quality control standards. The company primarily serves the domestic Chinese healthcare market through a robust distribution network.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Guangdong Baodan Pharmaceutical.